Approval · Notice of Compliance 32789 · 2024
NETSPOT: Notice of Compliance 32789
Issued February 28, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32789
- Date
- February 28, 2024
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative - Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NETSPOT | 02490005 | Marketed |
Medicinal ingredients
- OXODOTREOTIDE 40 MCG per UNIT